Clinical trial
Efficacy of Pimozide Augmentation for Clozapine Partial Response
NCT00374244 · Yale University, Other · Completed
Key facts
| NCT number | NCT00374244 |
|---|---|
| Title | Efficacy of Pimozide Augmentation for Clozapine Partial Response |
| Official title | Efficacy of Pimozide Augmentation for Clozapine Partial Response |
| Lead sponsor | Yale University, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Pimozide, placebo |
| Enrollment | 28 |
| Start date | Jan 1, 2004 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Sep 11, 2006 |
| Last update posted | Mar 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: